News Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:35:03 2024-04-17 am EDT			Pre-market 02:29:26 am
86.18 ^EUR	-0.70%		86.32	+0.17%

Apr. 17	IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets	MT
Apr. 17	BeiGene to Award Shares Worth $15 Million to 11 Directors	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets	Apr. 17	MT
BeiGene to Award Shares Worth $15 Million to 11 Directors	Apr. 17	MT
Sanofi's Frexalimab Reduces Disease Activity in Multiple Sclerosis Patients in Phase 2 Trial	Apr. 17	MT
Sanofi: new positive phase II results in MS	Apr. 17	CF
The 2023 Pharmaceutical Patent Review	Apr. 17	AQ
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis	Apr. 17	GL
INNATE PHARMA ANNOUNCES ADVANCEMENT OF SANOFI-DEVELOPED NK CELL ENGAGER SAR443579/IPH6101 PROGRESSING TO PHASE 2 FOR BLOOD CANCER PATIENTS	Apr. 16	AQ
IDT Australia Signs Master Service Agreement with Sanofi	Apr. 15	MT
Sanofi: progress in hematology trial	Apr. 15	CF
Innate Pharma: progress in hematology trial	Apr. 15	CF
Weight-Loss Drugs Like Wegovy Don't Cause Suicidal Thoughts, EU Says	Apr. 12	DJ
European Medicines Agency Finds No Increased Suicide Risk Linked to Weight-loss Drugs	Apr. 12	MT
EU regulator finds no link between weight-loss drugs and suicidal thoughts	Apr. 12	RE
Nurix Therapeutics Shares Climb 19% on Extended Sanofi Collaboration	Apr. 09	DJ
Nurix Therapeutics Extends Collaboration With Sanofi, Aims to Nominate Clinical Candidate	Apr. 09	MT
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6	Apr. 09	CI
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents	Apr. 08	GL
Sanofi Launches Rabies Vaccine in the UK	Apr. 05	MT
Sanofi: rabies vaccine launched in the UK	Apr. 05	CF
Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups	Apr. 05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Looking beyond the quarterly miss, Sanofi remains an attractive bet

February 01, 2024 at 11:26 am EST

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST